Structural biology plays a critical role in understanding biological mechanisms and accelerating drug discovery. Cryo-Electron Microscopy (Cryo-EM) has revolutionized this field by enabling the high-resolution analysis of biological macromolecules that are difficult or impossible to crystallize. This powerful technology allows researchers to visualize structures in a near-native state, capturing diverse conformational states and determining the structures of complex assemblies with minimal sample requirements.
For researchers and companies looking to harness the power of Cryo-EM, having access to a comprehensive cryo-EM platform and reliable cryo-EM access services is essential. This allows for efficient project execution from sample preparation to final structure determination.
ShuimuBio, founded in 2017 out of Tsinghua University, stands as a leading commercial platform offering comprehensive Cryo-EM solutions. With a core team comprising experts in life sciences, computational science, IT, and the pharmaceutical industry, ShuimuBio was established as Asia's first commercial platform providing Cryo-EM structural analysis services. Their expertise is built upon a deep foundation in structural biology from Tsinghua University.
A Global Leader in Cryo-EM Platform Infrastructure
A key aspect of a robust cryo-EM platform is its infrastructure. ShuimuBio boasts what the sources describe as the world's largest commercial cryo-EM platform by scale. This impressive facility includes eight 300 KV high-end Cryo-Electron Microscopes, with two located in Beijing and six in Hangzhou. These microscopes are equipped with advanced components such as high-performance detectors, energy filters, spherical aberration correctors, and phase plates to maximize imaging quality.
Maintaining peak performance is crucial for reliable cryo-EM access. Professional technical engineers are responsible for the daily operation, inspection, and maintenance of the Cryo-EM facilities, ensuring they function at optimal performance for every data collection session. The sources highlight the platform's commitment to daily maintenance and upkeep, guaranteeing high efficiency and quality data collection with stable and reliable service support. Each microscope maintains an annual availability of over 330 days, excluding fixed maintenance times, and boasts an annual fault-free operation rate exceeding 97%.
Beyond hardware, the cryo-EM platform incorporates advanced software solutions. ShuimuBio has independently developed the SMART software series, which leverages AI technology to enhance the efficiency of Cryo-EM data analysis. This AI-driven approach reduces machine runtime and required data volume, streamlining the entire analysis process.
Comprehensive Cryo-EM Services
ShuimuBio's offerings extend beyond basic imaging, providing a range of services that constitute a full cryo-EM platform for diverse research needs. These services are designed to offer a "one-stop" solution, significantly saving time and cost for researchers.
· Single Particle Analysis (SPA): SPA is a cornerstone Cryo-EM technique used to determine the high-resolution 3D structure of biological macromolecules like proteins and viruses. The process involves imaging numerous purified particles and using algorithms for processing and reconstruction. SPA is particularly effective for challenging targets such as difficult-to-crystalize proteins, Protacs, membrane proteins (GPCRs, ion channels, transporters), VLPs, peptides, and small molecule-target interactions. The platform has extensive experience, having completed over 300 SPA projects and solved structures as small as 51kDa with resolutions as high as 1.8 Å. The SPA workflow includes project consultation, evaluation, planning, contract, sample preparation, negative staining, freezing and data collection, 2D particle picking, 3D reconstruction, model refinement, and data delivery.
· MicroED Solutions: MicroED (Microcrystal Electron Diffraction) is a cutting-edge technique specifically designed to resolve high-resolution structures from microcrystals and nanocrystals, proving particularly useful for organic compounds, peptides, and small proteins. ShuimuBio provides precise structural insights using MicroED, with a high success rate of over 80% and achieving resolutions between 0.6 Å and 1.0 Å. They have developed the eTasED software, which integrates MicroED seamlessly into standard Cryo-EM systems without hardware modifications, boosting efficiency and accuracy.
· Negative Staining & Negative Staining 2D: Negative staining is a cost-effective electron microscopy technique providing initial low-resolution 2D projection images of macromolecules and complexes. It's valuable for quickly assessing sample characteristics such as particle size, homogeneity, oligomeric state, morphology, particle density, integrity, flexibility, and conformational/compositional heterogeneity. This technique is widely used for observing viruses, nanoparticles, organelles, and protein complexes. Negative staining 2D specifically focuses on analyzing structures arranged in 2D planes, like viruses or protein complexes, often achieving resolutions of 2-5 nanometers. It's a crucial initial step in the Cryo-EM workflow for sample characterization.
· Cryo-Characterization: This service uses ultra-low temperature techniques to maintain samples in a near-native state for high-resolution structural observation and analysis. It offers significant advantages for characterizing proteins, liposomes, exosomes, LNPs, AAV, and other virus vectors. ShuimuBio utilizes NanoSMART, an AI Cryo-EM system for automatic identification and characterization of nanoparticles from images, providing detailed reports on size distribution, circularity, lamellarity, fill/empty status, and integrity. This tool enhances clarity in low-quality images and improves recognition accuracy.
Addressing Sample Preparation Challenges
Sample quality is paramount for successful Cryo-EM. Traditional methods face challenges such as air-liquid interface absorption, severe preferred orientation, high sample concentration thresholds (>1 μM), significant background noise, and difficulty reconstructing small molecules. To overcome these limitations, ShuimuBio has developed proprietary graphene grid support films called GraFuture™. These grids offer a potential solution for preferred orientation issues and are particularly suited for samples with low molecular weight, low concentration, high background noise, air-liquid interface damage, and preferred orientation challenges. The GraFuture™ series includes both graphene oxide (GO) and reduced graphene oxide (RGO) versions.
Protein Services: The Foundation for Structure Determination
Cryo-EM structural analysis often begins with high-quality protein samples. Recognizing this, ShuimuBio has established a comprehensive protein expression and purification platform. This platform is designed to overcome the difficulties in preparing challenging proteins and improve the ability and level of protein structural analysis. The goal is a true one-stop solution from gene sequence to high-precision 3D protein structure.
Their protein services include:
· Protein Expression Systems: Offering various systems including E.coli, mammalian cells, insect cells, and cell-free systems, chosen based on protein type and requirements. Mammalian systems are preferred for therapeutic proteins, vaccines, and antibodies due to native-like folding and post-translational modifications.
· Protein Purification: Utilizing standard techniques like affinity chromatography, ion exchange chromatography, gel filtration chromatography, and RP-HPLC to achieve high purity.
· Protein Analysis & QC: Assessing protein purity and homogeneity via SDS-PAGE, BN-PAGE, and HPLC; verifying identity and modifications using mass spectrometry; and analyzing protein-protein or protein-molecule interactions using technologies like SPR, BLI, MST, and ITC. ShuimuBio emphasizes strict quality control based on Cryo-EM analysis to ensure samples meet research requirements.
· Antibody Discovery: Services cover antigen preparation, cell line construction, antibody generation using phage display libraries, screening, production, purification, and characterization (including ELISA, FACS, and affinity measurements like SPR and BLI).
· Protein Assay Services: Providing SPR, BLI, and ELISA services for detailed interaction analysis.
· Stock Protein List: Offering a list of readily available high-quality protein targets, including membrane proteins like GPCRs, ion channels, transporters, and kinases. Custom target services are also available.
Flexible Cryo-EM Access Models
Accessing a high-end cryo-EM platform can be tailored to specific project needs. ShuimuBio offers different avenues for cryo-EM access:
· One-Stop SPA Solution: This is the comprehensive service starting from protein preparation (if needed) through to final structure determination. It's ideal for researchers seeking a complete solution without managing individual steps. The process is managed end-to-end with regular progress meetings.
· Machine Time Service (24h): For experienced users or those with ready-to-image grids, ShuimuBio provides 24/7 machine time on their 300kV microscopes in Beijing and Hangzhou. This allows researchers to schedule data collection efficiently. They offer a 24-hour response time for booking requests and an urgent booking channel. Users can choose between online remote grid selection or selection guided by ShuimuBio scientists. Sample requirements for machine time are clearly defined, including purity, volume, buffer conditions, and advanced notification for shipping. Data is delivered promptly, requiring users to provide sufficient hard drive space (e.g., 4TB per day). This machine time offering represents a direct form of cryo-EM access.
Extensive Experience and Case Studies
The platform's capabilities are demonstrated by its extensive project experience. ShuimuBio has successfully completed over 400 Cryo-EM and MicroED structural projects for clients since 2017. They have resolved over 150 protein structures, with many achieving resolutions better than 3.5 Å. Case studies highlight successful structure resolution of ion channels, GPCRs, antibody-antigen complexes, and spliceosomes, resulting in numerous publications in prestigious international journals. Their MicroED service has successfully resolved structures of small molecules, peptides, and proteins, including Acetaminophen (0.65 Å) and Proteinase K (1.50 Å).
Applications Across Key Research Areas
The comprehensive cryo-EM platform and services offered by ShuimuBio have broad applications across crucial areas of life sciences and drug discovery:
· Vaccine Development: Cryo-EM provides near-atomic resolution structures of viruses, offering insights into invasion mechanisms critical for vaccine design. Examples include studies on SARS-CoV-2 Spike protein interaction with ACE2, influenza vaccine strategies, and antibody neutralization of measles virus. Cryo-EM also plays a vital role in vaccine quality control by assessing particle morphology, size, integrity, and aggregation. It aids in understanding antibody-vaccine antigen interactions and rapidly characterizing new viral variants to inform vaccine updates.
· Antibody Drug Development: Cryo-EM is invaluable for determining the high-resolution structure of antibody-antigen complexes, revealing binding mechanisms and epitopes crucial for optimizing antibody design. It helps study antibody drug mechanisms of action, including interaction with targets and signaling pathways. The technology supports the optimization of existing antibodies and the design of new ones with improved affinity and specificity. Crucially, it enables the resolution of challenging membrane protein targets like GPCRs, common targets for antibody drugs. By providing rapid, detailed structural information, Cryo-EM accelerates the antibody drug discovery process.
· Small Molecule Drug Discovery: Cryo-EM is highly applicable in small molecule drug R&D, primarily by resolving target structures such as membrane proteins and enzymes. It provides detailed insights into the binding sites and interactions of small molecules with their targets, aiding the design of highly selective and potent drugs. The technology is used to study drug-target interaction mechanisms, understanding how drugs activate or inhibit receptors and modulate signaling pathways. Cryo-EM also supports fragment-based drug discovery (FBDD) by revealing interaction details between small fragments and protein targets, facilitating lead identification and optimization. Similar to antibody drugs, Cryo-EM's speed in resolving structures like GPCRs accelerates the small molecule drug discovery process. It offers unique advantages in studying biased ligands for GPCRs, providing structural mechanisms for selective pathway modulation.
Choosing the Right Cryo-EM Partner
Selecting a provider for cryo-EM access means considering factors like experience, technology, team expertise, service models, and quality control. ShuimuBio highlights its competitive advantages, including:
· Advanced Facilities: Top-tier microscopes and computational platforms designed for high-quality structure resolution.
· Leading Team: PhD-level scientists with expertise in structural biology, protein science, and computational biology.
· Extensive Experience: Hundreds of projects successfully completed across diverse sample types.
· Commitment to Resolution: Driven to achieve the highest possible resolutions.
· AI Integration: Proprietary SMART software enhancing efficiency.
· One-Stop & Flexible Access: Services from sample prep to structure, including dedicated machine time.
· Sample Prep Expertise: Specialization in challenging membrane proteins and innovative solutions like GraFuture™.
· Quality Focus: Strict QC throughout the process, including Cryo-EM analysis.
Conclusion
Access to advanced Cryo-EM technology is no longer limited to large institutions. Commercial cryo-EM platforms like ShuimuBio provide researchers with essential cryo-EM access and comprehensive support services needed to push the boundaries of structural biology and drug discovery. From tackling challenging membrane proteins and small complexes to accelerating vaccine and drug development pipelines, a well-equipped platform with expert support and flexible access options is invaluable. By providing a seamless workflow from gene to structure and leveraging cutting-edge technology and AI, ShuimuBio empowers scientists to unlock the full potential of Cryo-EM.
To learn more about their comprehensive cryo-EM platform and how to gain cryo-EM access for your research projects, please visit https://shuimubio.com/.